
About Sharon Bio-Medicine Limited
Data last updated:
Sharon Bio-Medicine Limited is a public limited company based in Panvel, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 19 June 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1989PLC052251. Its GSTIN is 27AAACS8457L1ZS (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹47,952. It was formerly known as Sharon Synthochem Private Limited. It is led by directors including Mukeshkumar Siyaram Singh (Whole-Time Director) and Purushottam Sharma.
Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Panvel, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹204.22 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹23.18 Cr (net margin 11.4%) and EBITDA of ₹51.37 Cr (EBITDA margin 25.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has about 258 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Sa-Ford and Sharon Bio. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹2,595.42 Cr on record. Court records list 105 cases involving the company, including 22 filed by the company and 83 filed against it; 30 cases are pending. The company has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Aktinos Pharma Private Limited with revenue of ₹207.85 Cr.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website sharonbio.com.
Company details
CIN history
Sharon Bio-Medicine has one previous CIN (Corporate Identification Number): L24110MH1989PLC052251. The current CIN is U24110MH1989PLC052251, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110MH1989PLC052251 | Current |
| L24110MH1989PLC052251 | Previous |
Contact details
Sharon Bio-Medicine Limited's registered office is in Panvel, Maharashtra.
- Social Media
- Registered AddressPlot No. L6, MIDC Road, Panvel, Maharashtra, India – 410208
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sharon Bio-Medicine operates two associated brands: SA-FORD and Sharon Bio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides chemistry, toxicology testing, and regulatory studies for clients. | sa-ford.com | |
| Manufacturer of pharmaceutical intermediates, actives, and finished dosages | sharonbio.com |
Business activity
The main business activity of Sharon Bio-Medicine is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sharon Bio-Medicine Limited, buy the company report.
Financials of Sharon Bio-Medicine Limited
FY 2025 filings availableSharon Bio-Medicine Limited reported revenue of ₹204.22 Cr (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 20% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.2% | ||||
| Net Profit Margin | 11.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sharon Bio-Medicine Limited, buy the company report.
Board of directors of Sharon Bio-Medicine Limited
Sharon Bio-Medicine has 4 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purushottam Sharma | Director | 17 Jun 2023 | 3 Years 5 Months | Current |
| Mukeshkumar Siyaram Singh | Whole-Time Director | 17 Jun 2023 | 3 Years 5 Months | Current |
| Mahendar Korthiwada Also directs: Innova Captab Limited, Univentis Medicare Limited | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
| Jayant Vasudeo Rao Also directs: Innova Captab Limited | Director | 17 Jun 2023 | 3 Years 5 Months | Current |
Peer comparison
Sharon Bio-Medicine Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aktinos Pharma Private Limited | ₹207.85 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India | |||
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | 30.0% | Aran Road, Ameerpet, Hyd-016, Telangana, India | |||
| Inogent Laboratories Private Limited | ₹206.9 Cr (FY 2017) | 18.0% | Hyderabad, Telangana, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Swati Spentose Private Limited | ₹205.55 Cr (FY 2024) | 11.0% | Mumbai, Maharashtra, India | |||
| Sharon Bio-Medicine Limitedthis company | ₹204.22 Cr (FY 2025) | ₹23.18 Cr | 11.4% | -20.0% | Panvel, Maharashtra, India | |
| Orch Laboratories India Private Limited | ₹203 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Melody Healthcare Private Limited | ₹200.91 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| ZCL Chemicals Limited | ₹199.89 Cr (FY 2019) | 8.0% | Mumbai, Maharashtra, India | |||
| Shree Jee Laboratory Private Limited | ₹198.78 Cr (FY 2024) | -2.0% | New Delhi, Delhi, India | |||
| Daffodil Pharmachem Private Limited | ₹196.29 Cr (FY 2025) | -27.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sharon Bio-Medicine Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jul 2025 | 101157919 | State Bank of India | ₹25 Cr | Open | |
| 09 Sep 2015 | 10616310 | State Bank of India | ₹137.49 Cr | Satisfied | |
| 30 Mar 2015 | 10565945 | Sbicap Trustee Company Limited | ₹683.14 Cr | Satisfied | |
| 29 Dec 2014 | 10543298 | Canara Bank | ₹9 Cr | Satisfied | |
| 27 Sep 2014 | 10524338 | Union Bank of India | ₹6.6 Cr | Satisfied |
To see the full charge records of Sharon Bio-Medicine Limited, buy the company report.
Total charge records: 33 View all charges
Deals & funding
Sharon Bio-Medicine Limited has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | Funding round | ₹1 Cr | Investors: Univentis Medicare Limited , Univentis Medicare Limited & Manoj Kumar Lohariwala, Univentis Medicare Limited & Vinay Kumar Lohariwala |
| Mar 2019 | Market trade | ₹22.3 Lakh | Buyer: an individual Seller: Twin Earth Securities Private Limited |
| Sep 2016 | Market trade | ₹89.8 Lakh | Buyer: NBN Fintrade Private Limited Seller: NBN Fintrade Private Limited |
| Mar 2015 | Funding round | ₹66.83 Cr | Investors: Venus Global Management & Consultancy Services Private Limited , Ramco Properties Private Limited , Bagulvani General Trading Private Limited |
| Mar 2011 | Market trade | ₹99.1 Lakh | Buyer: Labh Capital Services Limited Seller: Sajal Finance and Investments Private Limited |
To see the full deal history of Sharon Bio-Medicine Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sharon Bio-Medicine Limited has 105 court cases on record: 22 filed by Sharon Bio-Medicine, 83 filed against it. 30 cases are pending and 75 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 72 | 57 | 23 |
| High courts | 16 | 9 | 4 |
| NCLAT | 12 | 12 | 3 |
| Supreme Court | 4 | 4 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 105)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, DHARWAD, Karnataka | Criminal complaint | Filed against the company by I C I C I Bank Ltd Hubballi | Pending |
| High Court of Kerala | Writ petition | Filed by the company against National Insurance Company Limited | Pending |
| High Court of Kerala | Court case (MACA) | Filed by the company against The New India Assurance Company Ltd | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed against the company by Sanjay Chemicals India Private Limited | Pending |
| District court, Ernakulam, Kerala | Court case (MA(Arb)) | Filed against the company by SML Finance Ltd | Disposed |
To see the full case history of Sharon Bio-Medicine Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sharon Bio-Medicine Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sharon Bio-Medicine has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACS8457L1ZS | Maharashtra | Active | 01 Jul 2017 |
| 05AAACS8457L1ZY | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sharon Bio-Medicine Limited, buy the company report.
Recent activity
Sharon Bio-Medicine Limited has 22 board changes on record since 2007: 4 appointments and 18 cessations. The latest: Kaushik Kamalapada Banerjee ceased to be Manager on 30 Apr 2025.
94 earlier events are in the company report.
Frequently asked questions
Sharon Bio-Medicine is an active public limited company based in Panvel, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 19 June 1989 (37+ years old) and is registered under CIN U24110MH1989PLC052251.
Sharon Bio-Medicine has 4 current directors:
- Mukeshkumar Siyaram Singh - Whole-Time Director
- Purushottam Sharma - Director
- Mahendar Korthiwada - Director
- Jayant Vasudeo Rao - Director
The latest financial statements of Sharon Bio-Medicine on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sharon Bio-Medicine is 27AAACS8457L1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAACS8457L1ZY (Uttarakhand).
The CIN (Corporate Identification Number) of Sharon Bio-Medicine is U24110MH1989PLC052251. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sharon Bio-Medicine has 105 court cases on record: 22 filed by the company and 83 filed against it. 30 are pending. Most are in the district courts.
Sharon Bio-Medicine was incorporated on 19 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.
Sharon Bio-Medicine has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023.
The peers of Sharon Bio-Medicine by revenue are Aktinos Pharma Private Limited, Nifty Labs Private Limited, Inogent Laboratories Private Limited, Smilax Laboratories Limited, Swati Spentose Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kaushik Kamalapada Banerjee ceased to be Manager on 30 Apr 2025. Mahendar Korthiwada ceased to be Additional Director on 09 Sep 2024. Mahendar Korthiwada was appointed as Director on 29 Nov 2023. Sharon Bio-Medicine has 22 board changes on record in total.
Sharon Bio-Medicine can be reached through the website sharonbio.com. Its registered office is in Panvel, Maharashtra, India.

